Frailty may confound the association between MASLD and cardiovascular mortality in people with cardiometabolic risk factors.
BACKGROUND While metabolic dysfunction-associated steatotic liver disease (MASLD) has been consistently associated with increased cardiovascular risk in the general population, its association with cardiovascular disease (CVD) mortality in adults with established cardiometabolic risk factor (including obesity, hyperten...